4//SEC Filing
WATERMAN ROBERT A 4
Accession 0001209191-21-029404
CIK 0000860730other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 8:37 PM ET
Size
23.7 KB
Accession
0001209191-21-029404
Insider Transaction Report
Form 4
WATERMAN ROBERT A
SVP & General Counsel
Transactions
- Sale
Common Stock
2021-04-29$202.90/sh−7,230$1,466,969→ 133,158 total - Sale
Common Stock
2021-04-28$198.75/sh−8,759$1,740,862→ 270,090 total - Sale
Common Stock
2021-04-28$199.53/sh−21,508$4,291,386→ 248,582 total - Sale
Common Stock
2021-04-29$200.30/sh−4,641$929,584→ 201,363 total - Sale
Common Stock
2021-04-28$200.24/sh−42,578$8,525,849→ 206,004 total - Sale
Common Stock
2021-04-29$201.09/sh−41,352$8,315,680→ 160,011 total - Sale
Common Stock
2021-04-29$201.96/sh−19,623$3,962,987→ 140,388 total - Sale
Common Stock
2021-04-30$203.06/sh−1,843$374,235→ 131,315 total
Footnotes (8)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.50 to $198.9875, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.995 to $199.91, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.92 to $200.91, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.56 to $201.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.57 to $202.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.58 to $203.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.00 to $203.21, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Issuer
HCA Healthcare, Inc.
CIK 0000860730
Entity typeother
Related Parties
1- filerCIK 0001216856
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 8:37 PM ET
- Size
- 23.7 KB